Bench
scale
Pilot
scale
Large
scale
Active
trials
Inactive
trials
Operations
FEB 2018 APR 2018 JU 2018 SEP 2018
NOV 2018
to present day
TBC
The design was
significantly
improved
using the
feedback given.
Initial
conversations
with commercial
partners.
Research
funding.
Extensive testing
in a mock-up
environment
with a view
towards on-site
deployments.
Conversations
and feedback at
demonstration
events or
seminars.
Regular
demonstrations
in the mock-up
environment.
Researchers
worked closely
with Sellafield
to fine tune
the platform
based on user
requirements, and
build confidence.
Interested
commercial
partner for
future funding
applications.
Inactive trials on
site gave further
chance for review
and feedback.
This also
highlighted what
was required
to get onto a
nuclear site.
Innovate UK
funding with
a commercial
partner, such
as Knowledge
Transfer
Partnerships.
Test facilities.
Following
successful
white trials,
the platform
was ready to be
tested on site.
Multiple active
trials have now
been completed
at Sellafield.
Test facilities
or deployment
opportunities.
The CARMA
platform now
has commercial
support from
the nuclear
supply chain.
DEVELOP DEPLOY OPERATE
4 7 5 8 6 9
27
